$12.45
14.54% today
Nasdaq, Feb 28, 04:51 pm CET
ISIN
US52634L1089
Symbol
LNSR

LENSAR Inc Stock price

$10.87
+0.17 1.59% 1M
+6.22 133.76% 6M
+1.93 21.59% YTD
+5.92 119.60% 1Y
+5.01 85.49% 3Y
+1.87 20.78% 5Y
+1.87 20.78% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
+1.40 14.78%
ISIN
US52634L1089
Symbol
LNSR
Sector

Key metrics

Market capitalization $126.25m
Enterprise Value $123.84m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.53
P/S ratio (TTM) P/S ratio 2.58
P/B ratio (TTM) P/B ratio 5.55
Revenue growth (TTM) Revenue growth 21.29%
Revenue (TTM) Revenue $48.87m
EBIT (operating result TTM) EBIT $-8.61m
Free Cash Flow (TTM) Free Cash Flow $-6.61m
Cash position $18.08m
EPS (TTM) EPS $-1.46
P/E forward negative
P/S forward 2.13
EV/Sales forward 2.08
Short interest 0.60%
Show more

Is LENSAR Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

LENSAR Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a LENSAR Inc forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a LENSAR Inc forecast:

Buy
100%

Financial data from LENSAR Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
49 49
21% 21%
100%
- Direct Costs 26 26
37% 37%
53%
23 23
7% 7%
47%
- Selling and Administrative Expenses 22 22
4% 4%
46%
- Research and Development Expense 5.46 5.46
13% 13%
11%
-4.86 -4.86
40% 40%
-10%
- Depreciation and Amortization 3.75 3.75
2% 2%
8%
EBIT (Operating Income) EBIT -8.61 -8.61
28% 28%
-18%
Net Profit -17 -17
28% 28%
-34%

In millions USD.

Don't miss a Thing! We will send you all news about LENSAR Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LENSAR Inc Stock News

Neutral
GlobeNewsWire
one day ago
31 ALLY Robotic Cataract Laser Systems™ placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company's total installed systems increased to approximately 385 as of December 31, 2024, representing a 26% increase over 2023 Fourth quarter 2024 revenue increased 38% over fourth quarter 2023; Full-year revenue increased 27% over 2023 Recurring revenue excee...
Neutral
GlobeNewsWire
9 days ago
ORLANDO, Fla., Feb. 19, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company's fourth quarter and full year 2024 financial results will be released before market open on Thursday, February 27, 2025. LENSAR's management will...
Positive
Seeking Alpha
23 days ago
LENSAR, Inc. is rated a Strong Buy by the Quant system, Wall Street analysts, and me, due to its innovative cataract treatment technology and growing market share. The company's ALLY Robotic Cataract Laser System has driven significant revenue and earnings growth, with a one-year price target of $15.15, a 42.21% increase. Despite competition from larger firms, LENSAR's disruptive technology, ex...
More LENSAR Inc News

Company Profile

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

Head office United States
CEO Nicholas Curtis
Employees 130
Founded 2004
Website www.lensar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today